APA (7th ed.) Citation

O, D., B, M., SG, N., B, P., M, M., K, G., . . . B, T. (2022). An mTORC1 to HRI signaling axis promotes cytotoxicity of proteasome inhibitors in multiple myeloma. Cell death & disease, 13(11), 969. https://doi.org/10.1038/s41419-022-05421-4

Chicago Style (17th ed.) Citation

O, Darawshi, et al. "An MTORC1 to HRI Signaling Axis Promotes Cytotoxicity of Proteasome Inhibitors in Multiple Myeloma." Cell Death & Disease 13, no. 11 (2022): 969. https://doi.org/10.1038/s41419-022-05421-4.

MLA (9th ed.) Citation

O, Darawshi, et al. "An MTORC1 to HRI Signaling Axis Promotes Cytotoxicity of Proteasome Inhibitors in Multiple Myeloma." Cell Death & Disease, vol. 13, no. 11, 2022, p. 969, https://doi.org/10.1038/s41419-022-05421-4.